Reporting its fourth quarter results for FY 26, Zydus Wellness, reported a consolidated growth of 62.1% in Net Sales which stood at Rs. 14,761 million as compared to Rs. 9,106 million in the corresponding period of the previous year.
Strides Pharma Science Ltd today announced its consolidated financial results for the quarter (Q4FY26) and Full Year (FY26) ended March 31, 2026. Badree Komandur, MD & Group CEO, commented on the performance and said, “Strides continued to deliver...
India’s pharmaceutical industry is under pressure as rising costs and an export slump squeeze drugmakers hard, impacting profits and slowing growth. Pharmaceutical companies, which have long benefited from strong overseas demand, are now facin...
AI is quietly transforming Indian healthcare. In radiology departments across Mumbai and Bengaluru, AI systems are diagnosing potential tumors in the scans even before the specialist opens the file.
Cancer drug research continues to transform the global pharmaceutical industry as companies race to develop affordable and advanced oncology treatments. New FDA clearances reflect rapid growth in cancer drug research, especially in the breast...
Glenmark Pharmaceuticals announced the launch of its affordable Vancomycin Hydrochloride for Injection USP in the U.S. market in two strengths, 500 mg/vial and 1 g/vial.
Every product we manufacture, every batch we release, and every process we design ultimately reaches a patient who places trust in our science, our systems, and our integrity. That is why quality must be embedded in every decision we make and...
The Bundibugyo virus is once again becoming a global health concern as scientists and health agencies closely monitor the latest Ebola outbreak in Central Africa. The rare virus, which belongs to the Ebola family, has sparked fresh fears after...
India launches Alzheimer’s drug Lormalzi by Eli Lilly, offering hope for early-stage patients with treatment designed to slow cognitive decline.
Karnataka has taken a giant leap in public health governance by launching its drug monitoring portal that automatically blocks the sale of substandard medicines.